Projects per year
Personal profile
Biography
Professor Rupert Leong is a Senior Staff Specialist gastroenterologist, Director of Endoscopy and Head of the Inflammatory Bowel Disease Services at Concord Hospital, Clinical Professor of Medicine at University of Sydney and Macquarie University, Sydney Australia. He was formally the Director of Gastroenterology at Bankstown Hospital, Conjoint Professor of Medicine at UNSW and Career Development Fellow (level 2 clinical) of the NHMRC. Prof Leong has made a substantial contribution to research with over 210 high quality scientific journals publications. Amongst these are senior authorship of national and international consensus guidelines in both Australia and in Asia. He is section editor of the Journal of Gastroenterology and Hepatology and on the international editorial boards of the American Journal of Gastroenterology, Alimentary Pharmacology and Therapeutics and Gastrointestinal Endoscopy.
Prof Leong is an executive member of a number of government bodies including the Agency for Clinical Innovation of NSW Health nominated for expertise in IBD and the Cancer Council of Australia Working Party on the revision of the clinical practice guidelines for colonoscopy and colorectal cancer, leading the section on surveillance colonoscopy in inflammatory bowel disease. Professor Leong was awarded the American Gastroenterological Association Fellowship by invitation on the basis of research excellence in 2012. He is the founding director of IBD Sydney, IBD School and IBD Masterclass.
As a clinician, Prof Leong is widely recognized for his endoscopy skills especially on the role of advanced imaging techniques and colon cancer diagnostic strategies. His private consultation rooms are at Macquarie University Hospital (Suite 404, 2 Technology Place, Macquarie Uni 98123880) on George St near Town Hall Station (Specialist Medical Services, Level 11, 501 George St, Sydney 83781721). His global reputation has led to speaking engagements and live endoscopy demonstrations around the world including in USA, Germany, China, Hong Kong, Singapore among others. He is a principle supervisor to PhD, MPhil and Masters by Research students and has supervised international gastroenterology fellows from Hong Kong, Singapore, Malaysia, Philippines, Sweden, UK, Wales, Ireland and Northern Ireland.
External positions
Director of IBD School
Fingerprint
- 1 Similar Profiles
Network
Projects
- 10 Active
-
APOLLO-CD: A Phase 2a, Multi-Center, Open-Label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of PRA023 in Subjects with Moderately to Severely Active Crohn’s Disease
Leong, R. & Chapman, N.
8/02/22 → 28/07/26
Project: Research
-
PRELUDE Study: A Study to Assess the Genotype of Subjects with Diagnosis of Ulcerative Colitis or Crohn’s Disease
Leong, R. & Chapman, N.
19/01/22 → 17/01/25
Project: Research
-
SER-301-001: A Seamless Phase 1B Study to Evaluate Safety, Tolerability and Efficacy of SER-301 in Adult Subjects with Active Mild-to-Moderate Ulcerative Colitis
Leong, R. & Chapman, N.
7/11/20 → 30/10/23
Project: Research
-
M14-675: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis
Leong, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.
17/12/19 → 24/09/24
Project: Other
Research Outputs
-
An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases
Waller, K. M. J., Leong, R. W. & Paramsothy, S., Feb 2022, In: Journal of Gastroenterology and Hepatology (Australia). 37, 2, p. 246-255 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Citations (Scopus) -
Combination therapy of immunomodulators with non-anti-tumor necrosis factor agents in inflammatory bowel disease: need more evidence?
Pudipeddi, A., Paramsothy, S. & Leong, R. W., Mar 2022, In: Clinical Gastroenterology and Hepatology. 20, 3, p. e640-e641 2 p.Research output: Contribution to journal › Letter › peer-review
-
Dual biologic therapy with ocrelizumab for multiple sclerosis and vedolizumab for Crohn’s disease: a case report and review of literature
Au, M., Mitrev, N., Leong, R. W. & Kariyawasam, V., 16 Mar 2022, In: World Journal of Clinical Cases. 10, 8, p. 2569-2576 8 p.Research output: Contribution to journal › Review article › peer-review
Open AccessFile -
Efficacy and safety of maintenance ustekinumab for ulcerative colitis through 3 years: UNIFI Long-term Extension
Abreu, M. T., Rowbotham, D. S., Danese, S., Sandborn, W. J., Miao, Y., Zhang, H., Tikhonov, I., Panaccione, R., Hisamatsu, T., Scherl, E. J., Leong, R. W., Arasaradnam, R. P., Afif, W., Peyrin-Biroulet, L., Sands, B. E. & Marano, C., 3 Mar 2022, (E-pub ahead of print) In: Journal of Crohn's and Colitis. 13 p.Research output: Contribution to journal › Article › peer-review
-
Gastroenterology team members’ knowledge and practices with fertility therapy for women with inflammatory bowel disease
Laube, R., Liu, E., Li, Y., Leong, R. W., Limdi, J. & Selinger, C., Mar 2022, In: Therapeutic Advances in Gastroenterology. 15, p. 1-10 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile
Prizes
-
-
Trans-Tasman Lecturer of RACP and NZ Society of Gastroenterology
Leong, Rupert (Recipient), 1 Jan 2015
Prize: Honorary award
Press / Media
-
Assisted reproduction awareness needed for IBD patients
27/10/21
1 item of Media coverage
Press/Media: Expert Comment
-
Professor Rupert Leong: patient preference should guide biologic choice
20/09/18
1 item of Media coverage
Press/Media: Expert Comment